Payment overview · 2025
General Payments
$57.04
2 reported records · 2 companies
Healthcare provider profile · identity verified
Wayne Nicholas Evancho, DO
Allopathic & Osteopathic Physicians|Family Medicine · NORTH MIAMI BEACH, FL · NPI 1619069804
Verified facts
What the public records show
CMS Open Payments records show Wayne Nicholas Evancho, DO received $57.04 in general payments during 2025 across 2 reported records.
Abbott Laboratories accounted for 50.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $28.98 | 50.8% | 1 | 2025 |
| Cipher Pharmaceuticals US LLC | Unresolved — no canonical attribution shown | $28.06 | 49.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $57.04 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ETERNA Normalized: eterna |
Device | Abbott Laboratories | $28.98 | 1 | 2025 |
Source payment records
|
|||||
| Natroba Normalized: natroba |
Drug | Cipher Pharmaceuticals US LLC | $28.06 | 1 | 2025 |
Source payment records
|
|||||
| Spinosad Normalized: spinosad |
Drug | Cipher Pharmaceuticals US LLC | $28.06 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 769 | 185 |
| Amlodipine Besylate | Amlodipine Besylate | 698 | 151 |
| Levothyroxine Sodium | Levothyroxine Sodium | 626 | 117 |
| Eliquis | Apixaban | 425 | 63 |
| Losartan Potassium | Losartan Potassium | 393 | 97 |
| Gabapentin | Gabapentin | 363 | 66 |
| Metformin Hcl | Metformin Hcl | 342 | 74 |
| Furosemide | Furosemide | 335 | 95 |
| Potassium Chloride | Potassium Chloride | 333 | 71 |
| Tamsulosin Hcl | Tamsulosin Hcl | 300 | 56 |
| Lisinopril | Lisinopril | 286 | 66 |
| Donepezil Hcl | Donepezil Hcl | 285 | 63 |
| Quetiapine Fumarate | Quetiapine Fumarate | 264 | 61 |
| Metoprolol Tartrate | Metoprolol Tartrate | 258 | 59 |
| Famotidine | Famotidine | 221 | 61 |
| Pantoprazole Sodium | Pantoprazole Sodium | 209 | 53 |
| Memantine Hcl | Memantine Hcl | 202 | 44 |
| Clopidogrel | Clopidogrel Bisulfate | 201 | 52 |
| Omeprazole | Omeprazole | 196 | 49 |
| Trazodone Hcl | Trazodone Hcl | 195 | 49 |
| Simvastatin | Simvastatin | 186 | 35 |
| Levetiracetam | Levetiracetam | 180 | 33 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 164 | 54 |
| Hydralazine Hcl | Hydralazine Hcl | 157 | 29 |
| Xarelto | Rivaroxaban | 148 | 26 |
| Mirtazapine | Mirtazapine | 146 | 40 |
| Metoprolol Succinate | Metoprolol Succinate | 143 | 37 |
| Carvedilol | Carvedilol | 142 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 125 | 35 |
| Glipizide | Glipizide | 111 | 22 |
| Latanoprost | Latanoprost | 111 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 106 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 104 | 91 |
| Nifedipine Er | Nifedipine | 99 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 94 | 25 |
| Tramadol Hcl | Tramadol Hcl | 94 | 34 |
| Baclofen | Baclofen | 93 | 17 |
| Sertraline Hcl | Sertraline Hcl | 91 | 25 |
| Trulicity | Dulaglutide | 90 | 17 |
| Allopurinol | Allopurinol | 83 | 19 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 83 | 14 |
| Lactulose | Lactulose | 81 | 31 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 80 | 41 |
| Risperidone | Risperidone | 80 | 18 |
| Finasteride | Finasteride | 76 | 17 |
| Ezetimibe | Ezetimibe | 74 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 74 | 23 |
| Lorazepam | Lorazepam | 73 | 33 |
| Fluticasone Propionate | Fluticasone Propionate | 72 | 33 |
| Labetalol Hcl | Labetalol Hcl | 72 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 70 | 13 |
| Prednisone | Prednisone | 70 | 31 |
| Warfarin Sodium | Warfarin Sodium | 70 | suppressed |
| Azithromycin | Azithromycin | 68 | 57 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 68 | 34 |
| Montelukast Sodium | Montelukast Sodium | 68 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 67 | 18 |
| Clonidine Hcl | Clonidine Hcl | 61 | 17 |
| Brimonidine Tartrate | Brimonidine Tartrate | 59 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 57 | 14 |
| Alendronate Sodium | Alendronate Sodium | 56 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | 15 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 54 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 54 | 21 |
| Atenolol | Atenolol | 53 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 53 | 30 |
| Bumetanide | Bumetanide | 52 | suppressed |
| Januvia | Sitagliptin Phosphate | 52 | suppressed |
| Procrit | Epoetin Alfa | 47 | suppressed |
| Timolol Maleate | Timolol Maleate | 46 | 11 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 45 | 24 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 44 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 44 | 11 |
| Temazepam | Temazepam | 43 | 16 |
| Cephalexin | Cephalexin | 42 | 30 |
| Divalproex Sodium | Divalproex Sodium | 42 | 12 |
| Meloxicam | Meloxicam | 42 | 16 |
| Novolog Flexpen | Insulin Aspart | 40 | 11 |
| Ibuprofen | Ibuprofen | 39 | 18 |
| Oxybutynin Chloride | Oxybutynin Chloride | 39 | suppressed |
| Ozempic | Semaglutide | 38 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | suppressed |
| Entresto | Sacubitril/Valsartan | 37 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 37 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 37 | 13 |
| Spironolactone | Spironolactone | 37 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 37 | suppressed |
| Alprazolam | Alprazolam | 36 | 13 |
| Carbamazepine | Carbamazepine | 36 | suppressed |
| Glipizide Er | Glipizide | 35 | suppressed |
| Hydrocortisone | Hydrocortisone | 35 | 20 |
| Metformin Hcl Er | Metformin Hcl | 35 | suppressed |
| Loperamide | Loperamide Hcl | 34 | 19 |
| Mupirocin | Mupirocin | 34 | 28 |
| Pravastatin Sodium | Pravastatin Sodium | 34 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 27 |
| Lacosamide | Lacosamide | 32 | suppressed |
| Nystatin | Nystatin | 32 | 21 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 32 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 31 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 31 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | suppressed |
| Sucralfate | Sucralfate | 29 | suppressed |
| Aripiprazole | Aripiprazole | 28 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 28 | suppressed |
| Levofloxacin | Levofloxacin | 27 | 23 |
| Megestrol Acetate | Megestrol Acetate | 27 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 27 | suppressed |
| Ramipril | Ramipril | 27 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 26 | suppressed |
| Digoxin | Digoxin | 26 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 26 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 26 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 25 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 25 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Clonazepam | Clonazepam | 24 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Folic Acid | Folic Acid | 23 | suppressed |
| Humalog | Insulin Lispro | 23 | suppressed |
| Metronidazole | Metronidazole | 23 | 19 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 23 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 22 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 20 | suppressed |
| Budesonide | Budesonide | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 17 |
| Ventolin Hfa | Albuterol Sulfate | 20 | suppressed |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 18 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Tradjenta | Linagliptin | 18 | suppressed |
| Celecoxib | Celecoxib | 17 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 17 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Metolazone | Metolazone | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | suppressed |
| Clonidine | Clonidine | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 14 |
| Minoxidil | Minoxidil | 14 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Permethrin | Permethrin | 13 | suppressed |
| Pregabalin | Pregabalin | 13 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Lubiprostone | Lubiprostone | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Ingrezza | Valbenazine Tosylate | 11 | suppressed |
| Jardiance | Empagliflozin | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 11 | suppressed |
| Propylthiouracil | Propylthiouracil | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $57.04 · 2 records | Abbott Laboratories | ETERNA, Natroba, Spinosad | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error